| Literature DB >> 19931579 |
Padmavathy Tallury1, Astha Malhotra, Logan M Byrne, Swadeshmukul Santra.
Abstract
New methods to identify trace amount of infectious pathogens rapidly, accurately and with high sensitivity are in constant demand to prevent epidemics and loss of lives. Early detection of these pathogens to prevent, treat and contain the spread of infections is crucial. Therefore, there is a need and urgency for sensitive, specific, accurate, easy-to-use diagnostic tests. Versatile biofunctionalized engineered nanomaterials are proving to be promising in meeting these needs in diagnosing the pathogens in food, blood and clinical samples. The unique optical and magnetic properties of the nanoscale materials have been put to use for the diagnostics. In this review, we focus on the developments of the fluorescent nanoparticles, metallic nanostructures and superparamagnetic nanoparticles for bioimaging and detection of infectious microorganisms. The various nanodiagnostic assays developed to image, detect and capture infectious virus and bacteria in solutions, food or biological samples in vitro and in vivo are presented and their relevance to developing countries is discussed. Copyright 2009 Elsevier B.V. All rights reserved.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19931579 PMCID: PMC7103339 DOI: 10.1016/j.addr.2009.11.014
Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN: 0169-409X Impact factor: 15.470
Summary of the NPs studied in the diagnosis of infectious pathogens.
| Pathogen | Nanomaterial | Recognition | Detection method | Efficiency/detection limit | Reference |
|---|---|---|---|---|---|
| Qdots | Biotinylated antibody | Fluorescence microscopy | 2 orders more sensitive than conventional dyes | ||
| Qdots and magnetic NPs | Antibody | Fluorometry | 100 times more sensitive than FITC | ||
| Qdots | Fim-H mannose-specific lectin | Fluorometry | 104 bacteria/ml | ||
| Dye-doped silica NPs | Antibody | Plate counting/flow cytometry | 1–400 | ||
| Surface plating | 1.6 × 101 to 7.2 × 107 CFU/ml | ||||
| Magnetic NPs | Antibody | IR spectroscopy | 104–105 CFU/ml | ||
| ATP bioluminescence | 20 CFU/ml | ||||
| Au NPs | Antibody | Microscope and visual | 10 ng | ||
| Eu doped silica NPs | Ca dipicolinate | Fluorescence spectra | 0.2 nM in 2 min | ||
| Eu doped polystyrene NPs | Antibody | Fluoroimmunoassay | 0.01–100 ng/ml | ||
| Dye-doped silica NPs | Antibody | Fluorescence microscopy | Amplified signal within 4 h | ||
| Au NPs | Oligonucleotide | UV–Vis spectroscopy | Visual detection | ||
| Magnetic NPs | Antibody | PCR | 226 CFU/.5 ml | ||
| Ag nanorod array | SERS | – | |||
| Magnetic NPs | vancomycin | MALDI-MS | 7 × 104 CFU/ml in urine | ||
| Magnetic NPs | Vancomycin | MALDI-MS | 7 × 104 CFU/ml in urine | ||
| CCMV | Antibody | Test strip | Visual detection | ||
| Au NPs | Antibody | I.C. Assay Test device | 100% Sensitivity | ||
| Cholera toxin | Liposomes | Gangliosides | Fluoroimmunoassay | 1 nM | |
| Au NPs | Thiolated lactose | Test strip | 10 fg/ml in 20 min | ||
| Visual and UV–Vis | 10 min | ||||
| Au NPs | Antibody | Test strip | Red dots appearance in 2 h | ||
| Au and magnetic NPs | DNA assay | Fluorescence | 1 ng/ml | ||
| Au NPs | Antibody | SEM | 10 ng | ||
| Gram-negative bacteria | Magnetic NPs | Vancomycin | Fluorescence microscopy | 4 CFU/ml | |
| SEC1 | Dye-doped Silica NPs | Antibody | Fluorescence microscopy | – | |
| Magnetic NPs | Antibody | TEM | 10 CFU/ml in human blood | ||
| Magnetic NPs | Vancomycin | Plate counting | – | ||
| P fimbriated | Magnetic NPs | Pigeon ovalbumin | MALDI-MS | ∼ 9.6 × 104 CFU/0.5 ml | |
| Qdots | Antibody | Fluorescence spectroscopy | 104 CFU/ml | ||
| Cholera toxin, ricin, Shinga-like toxin1, staphylococcal enterotoxin B | Qdots | Antibody | Fluroimmunoassay | In ng/ml quantity | |
| Dye-doped silica NPs | Antibody | Luminophore immunoassay | within 20 min | ||
| RSV | Qdots | Antibody | Color change | Single step/short time | |
| Ag nanorod array | SERS | – | |||
| Rotavirus | Ag nanorod array | – | SERS | – | |
| Influenza virus | Liposomes | Sialic acid on glycoproteins | Colorimetry | 1 HAUs | |
| HBV | Au NPs/Ag staining | Protein-A antibody | Protein chip assay | Color appears in 15 min | |
| NLO properties | 60 pM | ||||
| HSV-2 | Au NPs | Antibodies | I.C. assay | 100% Sensitivity | |
| HIV-1 DNA | Au NPs | Probe DNA | NLO properties | 100 pM | |
| HIV | Ag nanorod array | – | SERS | – | |
| H5N1 | Magnetic NPs | Antibody | MRI | 5 viral particles in 10 µl | |
| SQUID | 5 pg/ml | ||||
| Adenovirus | Eu doped polystyrene NPs | Antibody | Fluoroimmunoassay | 800 fold more sensitive than conventional immunoassays | |
| HBV, HCV, HIV | Qdots | Antibody | Fluorescence | 100 µl sample/1 h/50 times more sensitive | |
| Au nanowire barcoded | Thiolated DNA | Fluorescence imaging | |||
| Coated with silica | |||||
| HBV, HCV | Au NPs/Ag staining | Protein A | Protein chip assay | Visual detection | |
| Au NPs/Ag staining | Antibody | UV–Vis spectroscopy | 1.088 × 103 cells/ml | ||
| Eu doped polystyrene NPs | Antibody | Fluoroimmunoassay | – | ||
I.C. = Immunochromatographic; HAUS = hemagglutinating units.
Fig. 1Fluorescence emission spectra of Fort Orange Qdots before conjugation to IgG antibody (A), after conjugation (B), and after binding increasing amounts of B. subtilis variant niger spores (C,D).
Fig. 2Test strip assay format. CT in the reaction mixture binds to the gangliosides on the liposome surface. The CT–GM1-liposome complex migrates through the nitrocellulose test strip by capillary action until it reaches the analytical zone, where toxins in the complex are captured by immobilized antibodies. This binding zone is shown as the dark band on the test strip.
Fig. 3Barcoded metallic nanowires for multiplexed biodetection. (A) Nanowires with different patterns of Au and Ag segments are functionalized with different molecular beacon probe sequences, which are nonfluorescent in the absence of target strands. When a mixture of target molecules, in this case complementary to probes 1 and 2, is incubated with the mixture of barcoded nanowires, (B) some nanowire-bound probes become fluorescent because of complementary target binding. Reflectance and fluorescence microscope images are acquired for the identification of nanowires and quantification of fluorescence, respectively, and (C) mean fluorescence intensities are calculated from populations of individual nanowires of each barcode pattern, to quantify the amount of each target present.
Fig. 4Schematic of the bio-barcode assay: (A) formation of MNP-2nd DNA probe/target DNA/1st DNA probe-Au NPs-barcode DNA; (B) barcode DNA separation and release.
Fig. 5Representation of the vancomycin-d-alanyl–d-alanine interaction responsible for mediating the interaction between the NPs and the bacteria. The critical components for the strong H-bonding interaction both on the vancomycin molecule (the heptapeptide backbone) and the d-alanyl–d-alanine dipeptide exposed from the bacterial surface are highlighted.